19338005: deux (valeur de l'attribut)

SNOMED CT Concept\valeur de l'attribut\nombre\deux

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
deux	est un(e) (attribut)	modificateur adjectival général	false	Inferred relationship	Some
deux	est un(e) (attribut)	nombre	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Belladonna alkaloid 16.2 mg and opium 60 mg rectal suppository	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Dexamethasone 500 microgram/mL and tobramycin 3 mg/mL eye suspension	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Metformin and saxagliptin only product	Count of base of active ingredient	False	deux	Inferred relationship	Some
Metformin hydrochloride 1 g and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet	Count of base of active ingredient	False	deux	Inferred relationship	Some
Metformin and saxagliptin only product in oral dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Hydrocortisone valerate 2 mg/g cutaneous ointment	Has concentration strength numerator value (attribute)	False	deux	Inferred relationship	Some	1
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	Count of base of active ingredient	False	deux	Inferred relationship	Some
Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment	Count of base of active ingredient	False	deux	Inferred relationship	Some
Cetrimide 1.5 mg/mL and chlorhexidine gluconate 150 microgram/mL cutaneous solution	Count of base of active ingredient	False	deux	Inferred relationship	Some
Coal tar 50 mg/g and pine tar 50 mg/g cutaneous gel	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely olopatadine (as olopatadine hydrochloride) 2 milligram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength numerator value (attribute)	False	deux	Inferred relationship	Some	1
Nitroglycerin 2 mg prolonged-release buccal tablet	Has presentation strength numerator value (attribute)	False	deux	Inferred relationship	Some	1
Methylphenidate hydrochloride 2 mg/mL oral solution	Has concentration strength numerator value (attribute)	False	deux	Inferred relationship	Some	1
Ciprofloxacin 2 mg/mL ear solution	Has concentration strength numerator value (attribute)	False	deux	Inferred relationship	Some	1
Product containing precisely esterified estrogen 1.25 milligram and methyltestosterone 2.5 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Hydrocortisone 10 mg/mL and iodoquinol 10 mg/mL cutaneous cream	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely coal tar 60 milligram/1 milliliter and lecithin 4 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely hydrocortisone valerate 2 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	Has concentration strength numerator value (attribute)	False	deux	Inferred relationship	Some	1
Benzalkonium 2.5 mg/g and polyethylene 219 mg/g cutaneous gel	Count of base of active ingredient	False	deux	Inferred relationship	Some
Lactic acid 250 mg/g and salicylic acid 250 mg/g cutaneous ointment	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely salicylic acid 50 microgram/1 milligram and zinc oxide 200 microgram/1 milligram conventional release cutaneous powder (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely mequinol 20 milligram/1 milliliter and tretinoin 100 microgram/1 milliliter conventional release cutaneous solution (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely hydrocortisone acetate 10 milligram/1 milliliter and pramocaine hydrochloride 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely hydrocortisone acetate 25 milligram/1 milliliter and pramocaine hydrochloride 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely benzocaine 10 milligram/1 milliliter and triclosan 2 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Cetrimide 22.5 mg/mL and chlorhexidine gluconate 2.25 mg/mL cutaneous solution	Count of base of active ingredient	False	deux	Inferred relationship	Some
Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL and dexamethasone 1 mg/mL ear suspension	Count of base of active ingredient	False	deux	Inferred relationship	Some
Benzocaine 10 mg/mL and triclosan 2 mg/mL cutaneous spray	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely acetic acid 20 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear solution (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely cetrimide 5 milligram/1 milliliter and chlorhexidine gluconate (as chlorhexidine) 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely nitrofural 2 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Has concentration strength numerator value (attribute)	False	deux	Inferred relationship	Some	1
Product containing precisely esterified estrogen 625 microgram and methyltestosterone 1.25 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Nicotine (as nicotine polacrilex) 2 mg oral gum chewing gum	Has presentation strength numerator value (attribute)	False	deux	Inferred relationship	Some	1
Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug)	Has presentation strength numerator value (attribute)	False	deux	Inferred relationship	Some	1
Product containing precisely paracetamol 24 milligram/1 milliliter and promethazine hydrochloride 300 microgram/1 milliliter conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Mucin 63 mg and xylitol 39 mg oromucosal lozenge	Count of base of active ingredient	False	deux	Inferred relationship	Some
Theophylline 2 mg/mL oral solution	Has concentration strength numerator value (attribute)	False	deux	Inferred relationship	Some	1
Albuterol (as albuterol sulfate) 833 microgram/mL and ipratropium bromide 167 microgram/mL solution for inhalation	Count of base of active ingredient	False	deux	Inferred relationship	Some
Bupivacaine hydrochloride 2.5 mg/mL and epinephrine (as epinephrine bitartrate) 5 microgram/mL solution for injection	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Frangula 80 microgram/mg and Sterculia gum 620 microgram/mg oral granules	Count of base of active ingredient	False	deux	Inferred relationship	Some
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely cefepime (as cefepime hydrochloride) 2 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength numerator value (attribute)	False	deux	Inferred relationship	Some	1
Product containing precisely calcium carbonate 1.5 gram and colecalciferol 10 microgram/1 each conventional release chewable tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Ampicillin (as ampicillin sodium) 1 g and sulbactam (as sulbactam sodium) 500 mg powder for solution for injection vial	Count of base of active ingredient	False	deux	Inferred relationship	Some
Estrone 2 mg/mL suspension for injection	Has concentration strength numerator value (attribute)	False	deux	Inferred relationship	Some	1
Nafcillin (as nafcillin sodium) 2 g powder for solution for injection vial	Has presentation strength numerator value (attribute)	False	deux	Inferred relationship	Some	1
Product containing precisely ampicillin (as ampicillin sodium) 2 gram and sulbactam (as sulbactam sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Aspirin 500 mg and glycine 133 mg orodispersible tablet	Count of base of active ingredient	False	deux	Inferred relationship	Some
Alprazolam 2 mg orodispersible tablet	Has presentation strength numerator value (attribute)	False	deux	Inferred relationship	Some	1
Pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit powder for solution for injection vial	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely oxacillin (as oxacillin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength numerator value (attribute)	False	deux	Inferred relationship	Some	1
Product containing precisely cefotetan (as cefotetan disodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength numerator value (attribute)	False	deux	Inferred relationship	Some	1
Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet	Count of base of active ingredient	False	deux	Inferred relationship	Some
Calcium electrolyte 1.25 g and cholecalciferol 10 microgram chewable tablet	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely omeprazole 40 milligram and sodium bicarbonate 1.68 gram/1 sachet powder for conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Diazepam 2 mg/mL rectal solution	Has concentration strength numerator value (attribute)	False	deux	Inferred relationship	Some	1
Product containing precisely omeprazole 20 milligram and sodium bicarbonate 1.68 gram/1 sachet powder for conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Sodium benzoate 100 mg/mL and sodium phenylacetate 100 mg/mL solution for injection	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely insulin lispro 50 unit/1 milliliter and insulin lispro protamine 50 unit/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Porcine isophane insulin 70 unit/mL and porcine regular insulin 30 unit/mL suspension for injection	Count of base of active ingredient	False	deux	Inferred relationship	Some
Human isophane insulin 70 unit/mL and recombinant human regular insulin 30 unit/mL solution for injection	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Human isophane insulin 90 unit/mL and recombinant human regular insulin 10 unit/mL suspension for injection	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely human isophane insulin 85 unit/1 milliliter and recombinant human regular insulin 15 unit/1 milliliter conventional release suspension for injection (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Human isophane insulin 80 unit/mL and recombinant human regular insulin 20 unit/mL suspension for injection	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Human isophane insulin 75 unit/mL and recombinant human regular insulin 25 unit/mL suspension for injection	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen 500 milligram/1 each gastro-resistant oral tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Dextromethorphan hydrobromide 3 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution	Count of base of active ingredient	False	deux	Inferred relationship	Some
Acetaminophen 5 mg/mL and caffeine 650 microgram/mL oral solution	Count of base of active ingredient	False	deux	Inferred relationship	Some
Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 10.4 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely bromazine hydrochloride 2.5 milligram/1 milliliter and codeine phosphate 2 milligram/1 milliliter conventional release oral solution (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely guanfacine (as guanfacine hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength numerator value (attribute)	False	deux	Inferred relationship	Some	1
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution	Count of base of active ingredient	False	deux	Inferred relationship	Some
Brompheniramine maleate 400 microgram/mL and codeine phosphate 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	Has concentration strength numerator value (attribute)	False	deux	Inferred relationship	Some	1
Product containing precisely citalopram (as citalopram hydrobromide) 2 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength numerator value (attribute)	False	deux	Inferred relationship	Some	1
Product containing precisely ibuprofen 20 milligram/1 milliliter and pseudoephedrine hydrochloride 3 milligram/1 milliliter conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely methylprednisolone 2 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength numerator value (attribute)	False	deux	Inferred relationship	Some	1
Dibucaine 1 mg and prednisolone (as prednisolone sodium phosphate) 1.3 mg rectal suppository	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely ciprofloxacin 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug)	Has concentration strength numerator value (attribute)	False	deux	Inferred relationship	Some	1
Product containing precisely ciprofloxacin 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen (as naproxen sodium) 375 milligram/1 each gastro-resistant oral tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely codeine phosphate 1 milligram/1 milliliter and kaolin 300 milligram/1 milliliter conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely fenoterol 500 microgram and ipratropium 1.25 milligram/1 actuation conventional release solution for inhalation (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Buprenorphine (as buprenorphine hydrochloride) 8 mg and naloxone hydrochloride 2 mg sublingual tablet	Count of base of active ingredient	False	deux	Inferred relationship	Some
Dyphylline 6.67 mg/mL and guaifenesin 6.67 mg/mL oral solution	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely bupivacaine hydrochloride 7.5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Acetic acid 9 mg/g and oxyquinoline (as oxyquinoline sulfate) 250 microgram/g vaginal gel	Count of base of active ingredient	False	deux	Inferred relationship	Some
Calcium carbonate 6.25 mg/mL and cholecalciferol 2.2 unit/mL oral solution	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and calcipotriol 50 microgram/1 milliliter conventional release cutaneous lotion (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Diphenhydramine hydrochloride 20 mg/mL and zinc acetate 1 mg/mL cutaneous cream	Count of base of active ingredient	False	deux	Inferred relationship	Some

Start Previous Page 12 of 24 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
32597014	Two	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
33051000077117	deux	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
3442102012	2 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442103019	2	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
614921000077110	deux (valeur de l'attribut)	fr	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)